Sign in
POSTER: CT-1498 A Global Phase 1B Study of JNJ-90014496, A CD19/CD20 Bi-Specific Chimeric Antigen Receptor (CAR) T-Cell Therapy, in Patients (Pts) With Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL)
Abstract   Peer reviewed

POSTER: CT-1498 A Global Phase 1B Study of JNJ-90014496, A CD19/CD20 Bi-Specific Chimeric Antigen Receptor (CAR) T-Cell Therapy, in Patients (Pts) With Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL)

Krish Patel, Joanna Rhodes, Luke Mountjoy, Jacob Haaber Christensen, Martin Hutchings, Paul Shaughnessy, Nosha Farhadfar, Constantine Tam, John Baird, Aravind Ramakrishnan, …
Clinical lymphoma, myeloma and leukemia, Vol.25(Suppl. 1), pp.S330-S331
09/2025
DOI: 10.1016/S2152-2650(25)01488-0

View Online

Details

Metrics

5 Record Views
Logo image